CLO22-043: Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Large, Single-Center Observational Study

20223 citationsJournal Article

Authors

Frederique St. Pierre · Northwestern University

Jennifer Boyer · Northwestern University

Mariana Nieves · Northwestern University

Abstract

"CLO22-043: Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Large, Single-Center Observational Study" published on 31 Mar 2022 by National Comprehensive Cancer Network.

Topics & Keywords

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the National Comprehensive Cancer Network

Volume 20, Issue 3.5, pp. CLO22-043

DOI: 10.6004/jnccn.2021.7248

Field-Weighted Citation Impact: 0.46